Alliancebernstein L.P. Day One Biopharmaceuticals, Inc. Transaction History
Alliancebernstein L.P.
- $261 Billion
- Q1 2025
A detailed history of Alliancebernstein L.P. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 67,790 shares of DAWN stock, worth $471,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,790
Previous 68,000
0.31%
Holding current value
$471,140
Previous $861,000
37.63%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$44.7 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$41.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$40 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$31.5 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$28.2 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $511M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...